62 - Once-Weekly Semaglutide Reduces HbA1c and Body Weight Across Baseline HbA1c Subgroups in the SUSTAIN 1–5 and 7–10 Clinical Trials

Publication date: October 2020Source: Canadian Journal of Diabetes, Volume 44, Issue 7, SupplementAuthor(s): Oren Steen, Satish Garg, Cyrus Desouza, Charlotte Hindsberger, Azadeh Houshmand-Øregaard, Sascha Pilemann-Lyberg, John Petrie
Source: Canadian Journal of Diabetes - Category: Endocrinology Source Type: research